Pages that link to "Q40112653"

The following pages link to Antibody Mediated Delivery of Toxic Molecules to Antigen Bearing Target Cells (Q40112653):

Displaying 21 items.

• Third Gordon Hamilton-Fairley Memorial Lecture. Tumour markers—Where do we go from here? (Q36047986) (← links)
• Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin A. (Q36466737) (← links)
• The radiobiology of targeted radiotherapy (Q37592873) (← links)
• Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells (Q37618130) (← links)
• Monoclonal antibodies: clinical applications (Q38670749) (← links)
• Ricin: cytotoxicity, biosynthesis and use in immunoconjugates. (Q39704382) (← links)
• Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview (Q39740848) (← links)
• In Vitro and in Vivo Effects of Anti-Tumor Antibody Covalently Coupled to a Chemotactic Peptide (Q40147104) (← links)
• Targeting potential of antibody conjugates (Q40167085) (← links)
• Monoclonal antibodies in the treatment of cancer (Q40201565) (← links)
• Antibody-targeted polymer-bound drugs (Q41077922) (← links)
• Targeting of drugs to cell surface receptors (Q41506607) (← links)
• Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer (Q42172789) (← links)
• Cytotoxicity of a cell-reactive immunotoxin containing ricin A chain is potentiated by an anti-immunotoxin containing ricin B chain (Q42937066) (← links)
• Variants of lymphoid lines produced with ricin A-chain monoclonal antibody conjugates (Q50584704) (← links)
• The antileukemic efficacy of an immunotoxin composed of a monoclonal anti-Thy-1 antibody disulfide linked to the ribosome-inactivating protein gelonin (Q68822520) (← links)
• In vitro synergism between hybrid immunotoxins and chemotherapeutic drugs: relevance to immunotherapy of prostate carcinoma (Q68954583) (← links)
• Specific in vitro and in vivo drug localisation to tumour cells using a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids (Q69782427) (← links)
• Effect of specific anti-human leukaemia immunotoxins on the colony formation by human haematopoietic progenitors and by human leukaemia cells (Q69870756) (← links)
• Immunotoxins: A New Approach to Cancer Therapy (Q72775968) (← links)
• Intracellular Targeting with Low pH-triggered Bispecific Antibodies (Q73824761) (← links)